The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial introduction generated substantial profits, the expiration of its intellectual property protection opened the https://victornbxd503531.blogacep.com/47459149/the-copyright-and-big-pharma-a-volatile-bet